SARAH MURFEY: Open Payments
NPI 1558663344 · MOUNT PROSPECT, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 23 payments from 15 companies in 2025. Trend: 2023 $1,869 · 2024 $1,465 · 2025 $578
Food & beverage: $578
| Company | Payments | Amount |
|---|---|---|
| Olympus America Inc. | 4 | $130 |
| Astellas Pharma US Inc | 3 | $76 |
| Sumitomo Pharma America, Inc. | 2 | $59 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| Antares Pharma, Inc. | 2 | $35 |
| Verity Pharmaceuticals Inc. | 1 | $35 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| UROGEN PHARMA, INC. | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $24 |
Products named: iTIND System, XTANDI, ORGOVYX, Nubeqa, XYOSTED, Trelstar, LYNPARZA, ERLEADA.
Industry payments across IL — which companies pay providers there.
